Transplant Infectious Diseases: A Review of the Scientific Registry of Transplant Recipients Published Data

被引:32
作者
Kotton, C. N. [1 ]
Huprikar, S. [2 ]
Kumar, D. [3 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02115 USA
[2] Ichan Sch Med Mt Sinai, New York, NY USA
[3] Univ Hlth Network, Multiorgan Transplant Program, Toronto, ON, Canada
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; CONSENSUS GUIDELINES; CYTOMEGALOVIRUS; OUTCOMES; PROPHYLAXIS; RISK; TRANSMISSION; FAILURE;
D O I
10.1111/ajt.14195
中图分类号
R61 [外科手术学];
学科分类号
摘要
The Scientific Registry of Transplant Recipients (SRTR) serves to collect data on organ transplants performed in the United States. Although the infectious diseases data are limited and include mostly pretransplant serologies and other nonspecific infection-related outcomes, this multicenter data collection allows for insightful national data and the ability to monitor trends over time. We reviewed the published concise reports for each organ type in SRTR reports containing data from 2005 to 2014, and summarized our findings with respect to cytomegalovirus (CMV), Epstein-Barr virus, posttransplant lymphoproliferative disorder (PTLD), hepatitis B virus (HBV), hepatitis C virus (HCV), HIV, general infection, and prophylaxis. Our review highlights a few developments. While rates of donor-recipient CMV serology combinations remain fairly constant over time, there are generally more seronegative donors and recipients among living donor transplants. There has been a reduction in PTLD for pediatric transplant recipients. There has also been a slight reduction in anti-HBV core antibodypositive donor organs and stable reporting of HCV-positive donor organs and HIV-positive recipients.
引用
收藏
页码:1439 / 1446
页数:8
相关论文
共 34 条
[21]   Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients [J].
Locke, Jayme E. ;
Durand, Christine ;
Reed, Rhiannon D. ;
MacLennan, Paul A. ;
Mehta, Shikha ;
Massie, Allan ;
Nellore, Anoma ;
DuBay, Derek ;
Segev, Dorry L. .
TRANSPLANTATION, 2016, 100 (01) :141-146
[22]   A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients [J].
Locke, Jayme E. ;
Mehta, Shikha ;
Reed, Rhiannon D. ;
MacLennan, Paul ;
Massie, Allan ;
Nellore, Anoma ;
Durand, Christine ;
Segev, Dorry L. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (09) :2222-2229
[23]   OPTN/SRTR 2013 Annual Data Report: kidney [J].
Matas, A. J. ;
Smith, J. M. ;
Skeans, M. A. ;
Thompson, B. ;
Gustafson, S. K. ;
Stewart, D. E. ;
Cherikh, W. S. ;
Wainright, J. L. ;
Boyle, G. ;
Snyder, J. J. ;
Israni, A. K. ;
Kasiske, B. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 :1-34
[24]   Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation [J].
Palmer, Scott M. ;
Limaye, Ajit P. ;
Banks, Missy ;
Gallup, Dianne ;
Chapman, Jeffrey ;
Lawrence, E. Clinton ;
Dunitz, Jordan ;
Milstone, Aaron ;
Reynolds, John ;
Yung, Gordon L. ;
Chan, Kevin M. ;
Aris, Robert ;
Garrity, Edward ;
Valentine, Vincent ;
McCall, Jonathan ;
Chow, Shein-Chung ;
Davis, Robert Duane ;
Avery, Robin .
ANNALS OF INTERNAL MEDICINE, 2010, 152 (12) :761-+
[25]   Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States [J].
Quinlan, Scott C. ;
Pfeiffer, Ruth M. ;
Morton, Lindsay M. ;
Engels, Eric A. .
AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (02) :206-209
[26]   Effect of Cytomegalovirus Viremia on Subclinical Rejection or Interstitial Fibrosis and Tubular Atrophy in Protocol Biopsy at 3 Months in Renal Allograft Recipients Managed by Preemptive Therapy or Antiviral Prophylaxis [J].
Reischig, Tomas ;
Jindra, Pavel ;
Hes, Ondrej ;
Bouda, Mirko ;
Kormunda, Stanislav ;
Treska, Vladislav .
TRANSPLANTATION, 2009, 87 (03) :436-444
[27]   Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients [J].
Sampaio, Marcelo Santos ;
Cho, Yong W. ;
Shah, Tariq ;
Bunnapradist, Suphamai ;
Hutchinson, Ian V. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (07) :2971-2979
[28]   Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey [J].
San-Juan, R. ;
Manuel, O. ;
Hirsch, H. H. ;
Fernandez-Ruiz, M. ;
Lopez-Medrano, F. ;
Comoli, P. ;
Caillard, S. ;
Grossi, P. ;
Aguado, J. M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (06) :604.e1-604.e9
[29]   Shorter Waitlist Times and Improved Graft Survivals Are Observed in Patients Who Accept Hepatitis C Virus plus Renal Allografts [J].
Scalea, Joseph R. ;
Barth, Rolf N. ;
Munivenkatappa, Raghava ;
Philosophe, Benjamin ;
Cooper, Matthew ;
Whitlow, Victoria ;
LaMattina, John C. .
TRANSPLANTATION, 2015, 99 (06) :1192-1196
[30]   Human immunodeficiency virus infection and left ventricular assist devices: A case series [J].
Sims, Daniel B. ;
Uriel, Nir ;
Gonzalez-Costello, Jose ;
Deng, Mario C. ;
Restaino, Susan W. ;
Farr, Maryjane A. ;
Takayama, Hiroo ;
Mancini, Donna M. ;
Naka, Yoshifumi ;
Jorde, Ulrich P. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (09) :1060-1064